tickdelta
tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

TECHBio-Techne

Health care · Biotechnology · Nasdaq
TECH quote by TradingView
Headquarters
Minneapolis, MN
CEO
Kim Kelderman
Next results
around Feb 3, 2027
Compare with peers → Embed
All key numbers (40, from the latest 10-K and 10-Q) From EDGAR
EPS (ttm)1.10Sales (ttm)1.2BNet income (ttm)172.0MSales growth-0.4%EPS growth+152%Sales Q/Q+4.6%
Free cash flow308.2MGross margin65.8%Oper. margin19.6%Net margin14.0%FCF margin25.1%ROE7.9%
ROA6.5%R&D / sales7.8%Dividend0.32Debt/Eq0.18Curr. ratio2.28Cash350.0M
Op. cash flow (ttm)337.6MEBITDA349.2MEBITDA margin28.7%Net debt50.0MQuick ratio1.74Interest cover26.16
ROIC7.4%Payout ratio27.6%Tax rate24.4%Stock pay / sales3.4%Shares out.157.1MShares Y/Y-1.7%
Book / share13.79Cash / share2.23Sales / share7.82Asset turnover0.47Inventory turns2.13Days sales out.65
Sales 3Y CAGR+2.2%Sales 5Y CAGR+5.5%EPS 3Y CAGR-13.0%EPS 5Y CAGR+5.9%

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Changes in the numbers

FY2026 against FY2025
  • Revenue growth slowed to -0.4%+5.2% → -0.4% · Revenue FY2026 / revenue FY2025 − 1, against the same a year earlier · 10-K ↗
  • Operating margin widened to 20.7%8.4% → 20.7% · Operating income / revenue · 10-K ↗
What management wrote about it → · Every company →

TECH against Health care peers

Ten years, side by side → · All 60 →
GrowthProfitBalanceCleanInsiders
TECHPeer median

Each side 0 to 100, ranked against every company we cover: relative position on reported figures, not a buy score. How

Every dot is one of the 60 companies, the better end on the right. Hover a dot for the company.

Sales growth
-0.4%55th of 60 · median +7.1%
Net margin
14.0%22nd of 60 · median 9.6%
Return on equity
7.9%37th of 54 · median 13.1%
Free cash flow margin
25.1%6th of 56 · median 15.5%
Debt / equity (less is better)
0.186th of 49 · median 0.66
TECH and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthGross marginNet marginROEFCF marginDebt / equity
TECH Bio-Techne$1.2B -0.4%65.8%14.0%7.9%25.1%0.18
VEEV Veeva Systems$3.5B +16.3%75.0%29.3%13.7%--
WST West Pharmaceutical Services$3.4B +6.3%37.6%18.8%21.5%13.3%0.07
PODD Insulet Corporation$3.2B +30.7%71.9%13.4%27.1%8.2%0.61
RVTY Revvity$2.9B +3.7%-8.2%3.3%19.2%0.44
MRNA Moderna$2.5B -39.9%28.0%-110.5%-40.8%-78.0%0.09

From $1.1B of sales to $272.1M of profit

FY2022, from the 10-K income statement
Revenue to Gross profit: $756.5MRevenue to Cost of revenue: $349.1MGross profit to Operating profit: $296.6MGross profit to Operating expenses: $459.9MOperating profit to Net profit: $258.3MOperating profit to Tax: $38.3MOther income to Net profit: $13.7MOperating expenses to R&D: $87.1MOperating expenses to SG&A: $372.8M Revenue: $1.1B Revenue$1.1B +19% Y/Y Gross profit: $756.5M · 68% margin Gross profit$756.5M68% margin +20% Y/Y Cost of revenue: $349.1M · 32% of revenue Cost of revenue$349.1M32% of revenue Operating profit: $296.6M · 27% margin Operating profit$296.6M27% margin +25% Y/Y Other income: $13.7M · 1% of revenue Other income$13.7M1% of revenue Operating expenses: $459.9M · 42% of revenue Operating expenses$459.9M42% of revenue Net profit: $272.1M · 25% margin Net profit$272.1M25% margin +94% Y/Y Tax: $38.3M · 3% of revenue Tax$38.3M3% of revenue R&D: $87.1M · 8% of revenue R&D$87.1M8% of revenue SG&A: $372.8M · 34% of revenue SG&A$372.8M34% of revenue

Swipe sideways for the whole flow →

From $1.1B of sales to $285.3M of profit

FY2023, from the 10-K income statement and revenue by product
Consumables to Revenue: $917.7MInstruments to Revenue: $112.1MServices to Revenue: $85.8MRoyalty revenues to Revenue: $21.1MRevenue to Gross profit: $769.8MRevenue to Cost of revenue: $366.9MGross profit to Operating profit: $298.9MGross profit to Operating expenses: $470.9MOperating profit to Net profit: $245.7MOperating profit to Tax: $53.2MOther income to Net profit: $39.5MOperating expenses to R&D: $92.5MOperating expenses to SG&A: $378.4M Consumables: $917.7M · 81% Consumables$917.7M81% Instruments: $112.1M · 10% Instruments$112.1M10% Services: $85.8M · 8% Services$85.8M8% Royalty revenues: $21.1M · 2% Royalty revenues$21.1M2% Revenue: $1.1B Revenue$1.1B +3% Y/Y Gross profit: $769.8M · 68% margin Gross profit$769.8M68% margin +2% Y/Y Cost of revenue: $366.9M · 32% of revenue Cost of revenue$366.9M32% of revenue Operating profit: $298.9M · 26% margin Operating profit$298.9M26% margin +1% Y/Y Other income: $39.5M · 3% of revenue Other income$39.5M3% of revenue Operating expenses: $470.9M · 41% of revenue Operating expenses$470.9M41% of revenue Net profit: $285.3M · 25% margin Net profit$285.3M25% margin +5% Y/Y Tax: $53.2M · 5% of revenue Tax$53.2M5% of revenue R&D: $92.5M · 8% of revenue R&D$92.5M8% of revenue SG&A: $378.4M · 33% of revenue SG&A$378.4M33% of revenue

Swipe sideways for the whole flow →

From $1.2B of sales to $168.1M of profit

FY2024, from the 10-K income statement and revenue by product
Consumables to Revenue: $928.2MInstruments to Revenue: $108.3MServices to Revenue: $99.3MRoyalty revenues to Revenue: $23.3MRevenue to Gross profit: $769.7MRevenue to Cost of revenue: $389.3MGross profit to Operating profit: $206.7MGross profit to Operating expenses: $563.0MOperating profit to Net profit: $168.1MOperating profit to Tax & other: $38.6MOperating expenses to R&D: $96.7MOperating expenses to SG&A: $466.4M Consumables: $928.2M · 80% Consumables$928.2M80% Instruments: $108.3M · 9% Instruments$108.3M9% Services: $99.3M · 9% Services$99.3M9% Royalty revenues: $23.3M · 2% Royalty revenues$23.3M2% Revenue: $1.2B Revenue$1.2B +2% Y/Y Gross profit: $769.7M · 66% margin Gross profit$769.7M66% margin +0% Y/Y Cost of revenue: $389.3M · 34% of revenue Cost of revenue$389.3M34% of revenue Operating profit: $206.7M · 18% margin Operating profit$206.7M18% margin −31% Y/Y Operating expenses: $563.0M · 49% of revenue Operating expenses$563.0M49% of revenue Net profit: $168.1M · 15% margin Net profit$168.1M15% margin −41% Y/Y Tax & other: $38.6M · 3% of revenue Tax & other$38.6M3% of revenue R&D: $96.7M · 8% of revenue R&D$96.7M8% of revenue SG&A: $466.4M · 40% of revenue SG&A$466.4M40% of revenue

Swipe sideways for the whole flow →

From $1.2B of sales to $73.4M of profit

FY2025, from the 10-K income statement and revenue by product
Consumables to Revenue: $972.3MInstruments to Revenue: $112.1MServices to Revenue: $111.6MRoyalty revenues to Revenue: $23.7MRevenue to Gross profit: $790.3MRevenue to Cost of revenue: $429.4MGross profit to Operating profit: $102.3MGross profit to Operating expenses: $688.0MOperating profit to Net profit: $73.4MOperating profit to Tax & other: $28.9MOperating expenses to R&D: $99.5MOperating expenses to SG&A: $588.5M Consumables: $972.3M · 80% Consumables$972.3M80% Instruments: $112.1M · 9% Instruments$112.1M9% Services: $111.6M · 9% Services$111.6M9% Royalty revenues: $23.7M · 2% Royalty revenues$23.7M2% Revenue: $1.2B Revenue$1.2B +5% Y/Y Gross profit: $790.3M · 65% margin Gross profit$790.3M65% margin +3% Y/Y Cost of revenue: $429.4M · 35% of revenue Cost of revenue$429.4M35% of revenue Operating profit: $102.3M · 8% margin Operating profit$102.3M8% margin −51% Y/Y Operating expenses: $688.0M · 56% of revenue Operating expenses$688.0M56% of revenue Net profit: $73.4M · 6% margin Net profit$73.4M6% margin −56% Y/Y Tax & other: $28.9M · 2% of revenue Tax & other$28.9M2% of revenue R&D: $99.5M · 8% of revenue R&D$99.5M8% of revenue SG&A: $588.5M · 48% of revenue SG&A$588.5M48% of revenue

Swipe sideways for the whole flow →

From $1.2B of sales to $181.8M of profit

FY2026, from the 10-K income statement and revenue by product
Consumables to Revenue: $985.1MInstruments to Revenue: $110.6MServices to Revenue: $94.3MRoyalty revenues to Revenue: $25.0MRevenue to Gross profit: $799.1MRevenue to Cost of revenue: $416.0MGross profit to Operating profit: $251.9MGross profit to Operating expenses: $547.2MOperating profit to Net profit: $181.8MOperating profit to Tax & other: $70.0MOperating expenses to R&D: $94.8MOperating expenses to SG&A: $452.4M Consumables: $985.1M · 81% Consumables$985.1M81% Instruments: $110.6M · 9% Instruments$110.6M9% Services: $94.3M · 8% Services$94.3M8% Royalty revenues: $25.0M · 2% Royalty revenues$25.0M2% Revenue: $1.2B Revenue$1.2B +0% Y/Y Gross profit: $799.1M · 66% margin Gross profit$799.1M66% margin +1% Y/Y Cost of revenue: $416.0M · 34% of revenue Cost of revenue$416.0M34% of revenue Operating profit: $251.9M · 21% margin Operating profit$251.9M21% margin +146% Y/Y Operating expenses: $547.2M · 45% of revenue Operating expenses$547.2M45% of revenue Net profit: $181.8M · 15% margin Net profit$181.8M15% margin +148% Y/Y Tax & other: $70.0M · 6% of revenue Tax & other$70.0M6% of revenue R&D: $94.8M · 8% of revenue R&D$94.8M8% of revenue SG&A: $452.4M · 37% of revenue SG&A$452.4M37% of revenue

Swipe sideways for the whole flow →

Where each $100 of sales went

FY2022
FY2023
FY2024
FY2025
FY2026
  • Cost of revenue
  • R&D
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement →

Profitability

2 of 4
  • ✓
    Net margin above the peer median14.0% vs 9.6%
  • !
    Gross margin down over 5 years68.0% → 65.8%
  • !
    Return on equity below 15%7.9%
  • ✓
    A profit in every one of 10 years
Net margin, FY2017 to FY2026: 13.5% → 15.0%

Balance sheet

4 of 4
  • ✓
    Interest covered more than 5 timesOperating income is 26.2× interest expense
  • ✓
    Debt smaller than equityDebt / equity 0.18 on the latest balance sheet (peer median 0.66)
  • ✓
    Current assets cover current liabilitiesCurrent ratio 2.28
  • ✓
    Net debt under 3 years of free cash flow$50.0M net debt, 0.2 years
Debt / equity at each year end, FY2017 to FY2026: 0.36 → 0.09
What the debt is made of ↓

Cash and shareholders

3 of 4
  • ✓
    Free cash flow positive in every one of 10 years$263.2M last year
  • ✓
    Share count down over 5 years−3.0%
  • !
    Dividend per share not up over 5 years$0.32 → $0.32
  • ✓
    Cash from operations above net income$292.1M vs $181.8M
Free cash flow, FY2017 to FY2026: 128.5M → 263.2M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

What the debt is made of, and when it is due

balance sheet of Sep 30, 2026
Debt: $400.0M Debt$400.0M Long-term debt: $200.0M · 50% Long-term debt$200.0M · 50% Short-term borrowings: $200.0M · 50% Short-term borrowings$200.0M · 50%

Left: the debt lines on the balance sheet (XBRL). Right: the principal due each year, from the debt note's maturity schedule; it can differ a little from the balance sheet, which shows the debt net of discounts and fees. Leases are not counted. This company's debt note has no tagged lines yet, so fixed or floating rate is not shown. The full schedule →

Revenue and net income, FY2017 to FY2026

Revenue 1.2B Net income 181.8M
FY2017 revenue 563.0M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001437749-19-021760 FY2017 net income 76.1M · NetIncomeLoss, 0001437749-19-021760 563.0M FY2017 FY2018 revenue 643.0M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001437749-20-018754 FY2018 net income 126.2M · NetIncomeLoss, 0001437749-20-018754 643.0M FY2018 FY2019 revenue 714.0M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001437749-21-020980 FY2019 net income 96.1M · NetIncomeLoss, 0001437749-21-020980 714.0M FY2019 FY2020 revenue 738.7M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001558370-22-013935 FY2020 net income 229.3M · NetIncomeLoss, 0001558370-22-013935 738.7M FY2020 FY2021 revenue 931.0M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001558370-23-015226 FY2021 net income 140.4M · NetIncomeLoss, 0001558370-23-015226 931.0M FY2021 FY2022 revenue 1.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001558370-24-012430 FY2022 net income 272.1M · NetIncomeLoss, 0001558370-24-012430 1.1B FY2022 FY2023 revenue 1.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001558370-25-011716 FY2023 net income 285.3M · NetIncomeLoss, 0001558370-25-011716 1.1B FY2023 FY2024 revenue 1.2B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001104659-26-100322 FY2024 net income 168.1M · NetIncomeLoss, 0001558370-25-011716 1.2B FY2024 FY2025 revenue 1.2B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001104659-26-100322 FY2025 net income 73.4M · NetIncomeLoss, 0001558370-25-011716 1.2B FY2025 FY2026 revenue 1.2B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001104659-26-100322 FY2026 net income 181.8M · NetIncomeLossAvailableToCommonStockholdersBasic, 0001104659-26-100322 1.2B FY2026

From XBRL in each 10-K. Hover a bar for the line item and filing. Full financials →

TECH's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Annual Quarterly
Revenue1.2B
FY2017: 563.0MFY2018: 643.0MFY2019: 714.0MFY2020: 738.7MFY2021: 931.0MFY2022: 1.1BFY2023: 1.1BFY2024: 1.2BFY2025: 1.2BFY2026: 1.2B FY2018FY2020FY2022FY2024FY2026
Net income181.8M
FY2017: 76.1MFY2018: 126.2MFY2019: 96.1MFY2020: 229.3MFY2021: 140.4MFY2022: 272.1MFY2023: 285.3MFY2024: 168.1MFY2025: 73.4MFY2026: 181.8M FY2018FY2020FY2022FY2024FY2026
Free cash flow263.2M
FY2017: 128.5MFY2018: 149.4MFY2019: 156.2MFY2020: 153.5MFY2021: 307.9MFY2022: 280.4MFY2023: 216.1MFY2024: 236.1MFY2025: 256.6MFY2026: 263.2M FY2018FY2020FY2022FY2024FY2026
EPS (diluted)1.16
FY2017: 0.51FY2018: 0.83FY2019: 0.62FY2020: 1.46FY2021: 0.87FY2022: 1.66FY2023: 1.76FY2024: 1.05FY2025: 0.46FY2026: 1.16 FY2018FY2020FY2022FY2024FY2026
Dividend per share0.32
FY2017: 0.32FY2018: 0.32FY2019: 0.32FY2020: 0.32FY2021: 0.32FY2022: 0.32FY2023: 0.32FY2024: 0.32FY2025: 0.32FY2026: 0.32 FY2018FY2020FY2022FY2024FY2026
Diluted shares157.0M
FY2017: 150.0MFY2018: 152.2MFY2019: 155.6MFY2020: 157.6MFY2021: 161.9MFY2022: 164.1MFY2023: 161.9MFY2024: 160.8MFY2025: 159.7MFY2026: 157.0M FY2018FY2020FY2022FY2024FY2026

Revenue by business segment

year to Jun 30, 2026
RevenueSharevs year before
Protein Sciences 874.6M72.0% +0.5%
Diagnostics And Spatial Biology 336.4M27.7% -2.9%

10-K 0001104659-26-100322, segment and revenue notes (XBRL).

Revenue by product or service

year to Jun 30, 2026
RevenueSharevs year before
Product and Services 1.2B97.9% -0.5%
Consumables 985.1M81.1% +1.3%
Instruments 110.6M9.1% -1.3%
Royalty revenues 25.0M2.1% +5.5%

10-K 0001104659-26-100322, segment and revenue notes (XBRL).

Revenue by region

year to Jun 30, 2026
RevenueSharevs year before
United States 635.4M52.3% -7.0%
EMEA, excluding United Kingdom 294.2M24.2% +10.5%
Greater China 104.1M8.6% +3.6%
APAC, excluding Greater China 85.8M7.1% +11.1%
United Kingdom 56.3M4.6% +2.7%
Rest of World 39.3M3.2% +4.6%

10-K 0001104659-26-100322, segment and revenue notes (XBRL).

Income statement

From EDGAR
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue563.0M643.0M714.0M738.7M931.0M1.1B1.1B1.2B1.2B1.2B
Cost of revenue188.5M210.8M240.5M255.5M298.2M349.1M366.9M389.3M429.4M416.0M
Gross profit374.5M432.1M473.5M483.2M632.9M756.5M769.8M769.7M790.3M799.1M
R&D53.5M55.3M62.4M65.2M70.6M87.1M92.5M96.7M99.5M94.8M
SG&A200.4M240.6M264.4M260.6M325.0M372.8M378.4M466.4M588.5M452.4M
Operating income120.6M136.2M146.7M157.4M237.3M296.6M298.9M206.7M102.3M251.9M
Interest expense7.4M10.2M21.7M19.2M14.0M11.3M11.2M15.7M8.5M9.6M
Pretax income112.0M126.0M112.0M276.5M148.2M301.4M338.7M185.7M98.5M240.7M
Income tax35.9M-198K15.9M47.2M8.6M38.3M53.2M17.6M25.1M58.8M
Net income76.1M126.2M96.1M229.3M140.4M272.1M285.3M168.1M73.4M181.8M
EPS (diluted)0.510.830.621.460.871.661.761.050.461.16
Diluted shares150.0M152.2M155.6M157.6M161.9M164.1M161.9M160.8M159.7M157.0M
Depreciation & amortization60.0M64.5M78.2M82.7M87.7M101.1M107.2M111.7M109.9M97.4M
EBITDA180.6M200.6M224.9M240.2M325.0M397.7M406.2M318.4M212.2M349.2M
Gross margin66.5%67.2%66.3%65.4%68.0%68.4%67.7%66.4%64.8%65.8%
Operating margin21.4%21.2%20.5%21.3%25.5%26.8%26.3%17.8%8.4%20.7%
Net margin13.5%19.6%13.5%31.0%15.1%24.6%25.1%14.5%6.0%15.0%
Revenue growth-+14.2%+11.0%+3.5%+26.0%+18.7%+2.8%+2.0%+5.2%-0.4%
EPS growth-+63.1%-25.4%+136%-40.2%+90.8%+6.0%-40.3%-56.2%+152%

Balance sheet

From EDGAR
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash91.6M122.0M100.9M146.6M199.1M172.6M180.6M151.8M162.2M264.7M
Short-term investments----32.5M74.5M23.7M1.1M--
Receivables116.8M120.3M137.5M122.5M145.4M194.5M218.5M241.4M206.9M216.6M
Inventory85.6M85.6M91.0M103.2M116.7M141.1M171.6M179.7M189.4M195.7M
Current assets348.0M398.4M412.6M520.9M510.6M605.6M621.5M617.4M608.3M744.4M
Property & equipment135.1M145.3M154.0M176.8M207.9M223.2M226.2M251.2M245.7M231.8M
Goodwill579.0M597.9M732.7M728.3M843.1M822.1M872.7M972.7M980.9M975.4M
Total assets1.6B1.6B1.9B2.0B2.3B2.3B2.6B2.7B2.6B2.6B
Accounts payable16.9M18.5M16.2M23.1M29.4M33.9M25.7M38.0M25.3M26.7M
Current liabilities135.5M79.5M102.0M106.7M152.3M176.0M128.5M159.4M175.8M163.7M
Total debt343.8M339.0M505.2M356.7M341.3M255.9M350.0M319.0M346.0M200.0M
Shareholders' equity949.6M1.1B1.2B1.4B1.6B1.7B2.0B2.1B1.9B2.1B
Retained earnings799.0M876.9M931.9M1.1B1.1B1.1B1.3B1.3B1.1B1.1B

Cash flow

From EDGAR
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow143.7M170.4M181.6M205.2M352.2M325.3M254.4M299.0M287.6M292.1M
Capital spending15.2M20.9M25.4M51.7M44.3M44.9M38.2M62.9M31.0M28.9M
Free cash flow128.5M149.4M156.2M153.5M307.9M280.4M216.1M236.1M256.6M263.2M
Stock-based pay (added back)14.6M28.2M32.3M32.4M49.0M42.2M39.2M38.0M40.8M41.4M
Dividends paid47.3M48.0M48.4M48.9M49.6M50.2M50.3M50.4M50.4M49.9M
Buybacks-015.4M50.1M43.2M160.9M19.6M80.0M275.7M41.7M
Acquisitions253.8M67.9M289.5M0225.4M-101.2M169.7M--
Investing cash flow-306.0M-38.7M-336.8M27.1M-243.5M-96.9M-265.6M-203.0M-35.2M-18.2M
Financing cash flow189.1M-99.2M134.4M-183.8M-62.6M-242.9M22.6M-122.4M-253.9M-169.1M
Dividend per share0.320.320.320.320.320.320.320.320.320.32

Stock-based pay and leases

From EDGAR
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Stock-based pay (expense)14.6M28.2M32.3M32.4M49.0M42.2M39.2M38.0M40.8M41.4M
Stock-based pay / revenue2.6%4.4%4.5%4.4%5.3%3.8%3.5%3.3%3.3%3.4%
Operating lease cost-----14.4M15.9M18.2M17.4M18.1M
Operating lease cash paid---12.8M13.5M14.9M14.9M17.7M16.3M18.1M
Right-of-use assets--071.5M73.8M65.6M98.3M91.3M73.4M67.3M
Operating lease liabilities--076.8M79.2M70.1M105.0M100.5M98.1M89.1M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Work on TECH in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/TECH/export.csv") into a cell.